CPG
CRDF icon

Cornerstone Planning Group’s Cardiff Oncology CRDF Stock Holding History

Cornerstone Planning Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$8 – 1843
2025
Q4 		$8 Hold
5
– – ﹤0.01% 1698
2025
Q3 		$11 Hold
5
– – ﹤0.01% 1682
2025
Q2 		$13 Hold
5
– – ﹤0.01% 1513
2025
Q1 		$15 Hold
5
– – ﹤0.01% 1533
2024
Q4 		$17 Hold
5
– – ﹤0.01% 1382
2024
Q3 		$16 Hold
5
– – ﹤0.01% 1282
2024
Q2 		$11 Hold
5
– – ﹤0.01% 1240
2024
Q1 		$18 Hold
5
– – ﹤0.01% 1080
2023
Q4 		$7 Hold
5
– – ﹤0.01% 952
2023
Q3 		$7 Buy
+5
New +$8 ﹤0.01% 1196

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Cornerstone Planning Group's CRDF Position: Q1 2026 in Review

Cornerstone Planning Group sold out of Cardiff Oncology (CRDF) in Q1 2026, closing a stake of 5 shares — an estimated $8 sold.

Cornerstone Planning Group first reported a position in CRDF in Q3 2023 and held it in 10 quarters. The position peaked at $18 in Q1 2024. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Cornerstone Planning Group reported no remaining Cardiff Oncology position as of Q1 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 5 Cardiff Oncology shares in Q1 2026, an estimated $8.
  • Cornerstone Planning Group first reported a position in Cardiff Oncology in Q3 2023 and held it in 10 quarters.
  • Cornerstone Planning Group's Cardiff Oncology position peaked at $18 in Q1 2024.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.